---
title: Research
description: Research
image: https://source.unsplash.com/BcoGknSqlDc/2000x1322?a=.png
---

<div style="background-color:black;color:white;padding:20px;">
	<br>
	<br>
	<br>
	<h2 align="center">Research</h2>
</div>


<div class="content">
	<section class="info" id="learn-more">
		<div class="container flex">
			<div class="text">
				<h2 class="editable">Machine Learning-Empowered Quantitative Pathology</h2>
				<p class="editable">I spearheaded the first fully-automated analytical workflow that extracted 9,879 quantitative features from digital whole-slide histopathology images. Whole-slide histopathology images contain billions of pixels and are difficult to process. To address this challenge, I established image processing modules to identify the regions of interest and extract features describing the size, shape, and pixel intensity distribution of the cell nuclei and cytoplasm. The extracted features from lung cancer histopathology slides successfully predicted patients’ diagnoses and prognoses. I further incorporated patients’ quantitative histopathology features with their transcriptomic profiles to identify the associations between molecular pathways and histology morphology of lung adenocarcinoma. These works lay the foundation of quantitative digital pathology analysis.</p>
				<p><strong>Selected publications:</strong></p>
				<p>a.   Kun-Hsing Yu, Ce Zhang, Gerald J. Berry, Russ B. Altman, Christopher Ré, Daniel L. Rubin, Michael Snyder. Predicting Non-Small Cell Lung Cancer Prognosis by Fully Automated Microscopic Pathology Image Features. Nature Communications. 2016 Aug 16;7:12474. <a href="https://www.ncbi.nlm.nih.gov/pubmed/27527408" target="_blank">[PubMed]</a> <a href="http://www.nature.com/articles/ncomms12474#supplementary-information" target="_blank">[Source Codes]</a> <a href="https://stanfordmedicine.box.com/s/gz93xcyynyie80gx90v6h2v77vy1w57m" target="_blank">[Dataset of Image Features]</a></p>
				<p>b.   Kun-Hsing Yu, Gerald J. Berry, Daniel L. Rubin, Christopher Ré, Russ B. Altman, Michael Snyder Association of Omics Features with Histopathology Patterns in Lung Adenocarcinoma. Cell Systems. 2017 Dec 27;5(6):620-627.e3. <a href="https://www.ncbi.nlm.nih.gov/pubmed/29153840" target="_blank">[PubMed]</a></p>
				<p>c.   Kun-Hsing Yu. Quantitative Pathology Analysis and Diagnosis using Neural Networks. U.S. Patent Application No.: 16/179,101. <a href="https://patents.google.com/patent/US20190147592A1/en" target="_blank">[Patent]</a></p>
				<p>d.  Kun-Hsing Yu, Andrew L. Beam, Isaac S. Kohane. Artificial Intelligence in Healthcare. Nature Biomedical Engineering. 2018 Oct. 10;2:719–731. <a href="https://www.ncbi.nlm.nih.gov/pubmed/31015651" target="_blank">[Paper]</a></p>
			</div>
			<div class="image">
				<img class="editable" src="http://placehold.it/650x1300" alt="Screenshot" />
			</div>
		</div>
	</section>

	<section class="info">
		<div class="container flex">
			<div class="text">
				<h2 class="editable">Bioinformatics Methods for Multi-Omics Data Analyses</h2>
				<p class="editable">My early work focused on the development of bioinformatics methods for human proteome analysis. High-throughput proteomics methods generate gigabytes of raw data. To fully utilize this rich information source, I established a computational framework that integrates proteomic and genomic data to characterize the genome-proteome correlation. Using the algorithms I devised, we identified biomarkers for chemotherapy resistance in ovarian cancer patients and early stage markers for colorectal cancer. These biomarkers were validated in a separate test set not involved in the model training.</p>
				<p>Selected publications:</p>
				<p>a.   Kun-Hsing Yu, Douglas A. Levine, Hui Zhang, Daniel W. Chan, Zhen Zhang, Michael Snyder. Predicting Ovarian Cancer Patients' Clinical Response to Platinum-based Chemotherapy by their Tumor Proteomic Signatures. Journal of Proteome Research. 2016 Aug 5;15(8):2455-65. <a href="https://www.ncbi.nlm.nih.gov/pubmed/27312948" target="_blank">[PubMed]</a></p>
				<p>b.   Kun-Hsing Yu, Michael Snyder. Omics profiling in precision oncology. Molecular & Cellular Proteomics. 2016 Aug;15(8):2525-36. <a href="https://www.ncbi.nlm.nih.gov/pubmed/27099341" target="_blank">[PubMed]</a></p>
				<p>c.   Hui Zhang, Tao Liu, Zhen Zhang, Samuel H Payne, Jason E McDermott, Jian-Ying Zhou, Vladislav A Petyuk, Lily Chen, Debjit Ray, Shisheng Sun, Feng Yang, Bai Zhang, Jing Wang, Seong Won Cha, Lijun Chen, Sunghee Woo, Punit Shah, Paul Aiyetan, Yuan Tian, Caitlin Choi, Marina A Gritsenko, Ronald J Moore, Matthew E Monroe, Kun-Hsing Yu, David Tabb, David Fenyo, Vineet Bafna, Joseph Wang, Ie-Ming Shih, Akhilesh Pandey, Bing Zhang, Michael Snyder, Doug Levine, Richard D Smith, Daniel W Chan, Karin D Rodland and the TCGA investigators. Deep proteogenomic characterization of human ovarian cancer. Cell. 2016 Jul 28;166(3):755-65. <a href="https://www.ncbi.nlm.nih.gov/pubmed/27372738" target="_blank">[PubMed]</a></p>
				<p>d.   Chia-Li Han, Jinn-Shiun Chen, Err-Cheng Chan, Chien-Peng Wu, Kun-Hsing Yu, Chia-Feng Tsai, Guei-Tian Chen, Chih-Wei Chien, Yung-Bin Kuo, Pei-Yi Lin, Chung-Chuan Chan, Jao-Song Yu, Yu-Ju Chen. An Informatics-assisted Label-free Approach for Personalized Tissue Membrane Proteomics: Case Study on Colorectal Cancer. Molecular & Cellular Proteomics. 2011 Apr;10(4):M110.003087. <a href="https://www.ncbi.nlm.nih.gov/pubmed/21209152" target="_blank">[PubMed]</a></p>
			</div>
			<div class="image">
				<img class="editable" src="http://placehold.it/650x1300" alt="Screenshot" />
			</div>
		</div>
	</section>

</div>
